Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors
- 21 October 2020
- journal article
- letter
- Published by SAGE Publications in Journal of Oncology Pharmacy Practice
- Vol. 26 (8), 2068-2069
- https://doi.org/10.1177/1078155220967100
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitorsJournal of Oncology Pharmacy Practice, 2020
- COVID-19 and off label use of drugs: an ethical viewpointDARU Journal of Pharmaceutical Sciences, 2020
- LOW INCIDENCE RATE OF OPPORTUNISTIC AND VIRAL INFECTIONS DURING IMATINIB TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS IN EARLY AND LATE CHRONIC PHASEMediterranean Journal of Hematology and Infectious Diseases, 2011